Food and Drug Administration

Description

The purpose of this study is to evaluate existing tools and to develop new methods to monitor the drug safety, efficacy, usage, and substitution patterns of model authorized generics in different therapeutic categories in comparison with those of brand name drugs and other generic drugs. The outcome of this study will help determine whether any potential bias against generic drugs is involved in generic drug complaints and affects generic substitution.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others
• Unrestricted

Contact

Martin Bernard <br/>Grants Management Specialist <br/>Phone 240-402-7564
Martin.Bernard@fda.hhs.gov